Merck Will Partner With Johnson & Johnson To Boost Vaccine Production

President Joe Biden announced on Tuesday that pharmaceutical giant Merck will partner with Johnson & Johnson to help boost vaccine production. While the two companies are traditionally rivals in the pharmaceutical and vaccine market, Johnson & Johnson is expecting rollout delays after their initial 3.9 million doses shipped Monday. Merck announced at the end of February that they would discontinue their research into a COVID-19 vaccine and focus efforts on manufacturing the J&J vaccine. “Merck remains steadfast in our commitment to contribute to the global response to the pandemic and to prepa…

Read More

HEDGE accordingly